Sulfamethizole

CHEMBL1191 Phase 4 Approuvé Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

270.3 g/mol

LogP

0.5

Phase

4

Sulfamethizole is a short-acting sulfonamide antibiotic with high urinary concentrations used specifically for the treatment of uncomplicated urinary tract infections caused by susceptible gram-positive and gram-negative bacteria. Its rapid renal excretion achieves high antibacterial concentrations in urine, making it particularly suited for lower urinary tract infections. Like all sulfonamides, it inhibits bacterial dihydropteroate synthase to block folate synthesis.

Masse moléculaire

270,3000 g/mol

LogP

0,50

TPSA

135,00 Å²

Règle des 5 de Lipinski

Conforme

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

Cc1nnc(NS(=O)(=O)c2ccc(N)cc2)s1

InChI

InChI=1S/C9H10N4O2S2/c1-6-11-12-9(16-6)13-17(14,15)8-4-2-7(10)3-5-8/h2-5H,10H2,1H3,(H,12,13)

Molecular Formula

C9H10N4O2S2

HBD / HBA

2 / 7

Liaisons Rotatives

3

Atomes Lourds

17

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

Sulfamethizole is a short-acting sulfonamide antibiotic with high urinary concentrations used specifically for the treatment of uncomplicated urinary tract infections caused by susceptible gram-positive and gram-negative bacteria. Its rapid renal excretion achieves high antibacterial concentrations in urine, making it particularly suited for lower urinary tract infections. Like all sulfonamides, it inhibits bacterial dihydropteroate synthase to block folate synthesis.

Yes, Sulfamethizole is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1191. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 5328. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Vous cherchez des informations accessibles aux patients ?

Sulfamethizole sur PillFYI

Structure

Données Clés

Formule: C9H10N4O2S2

Liens externes

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.